The Place of Sulfonylureas in Guidelines: Why Are There Differences?

This review describes a presentation at a recent symposium entitled “SUs in the treatment of T2DM: a fresh look and new insights” on Wednesday September 18, 2019 at the 55th Annual Meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain. It examines the current role...

Descripción completa

Detalles Bibliográficos
Autor principal: Amod, Aslam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261304/
https://www.ncbi.nlm.nih.gov/pubmed/32323155
http://dx.doi.org/10.1007/s13300-020-00811-3
_version_ 1783540479611109376
author Amod, Aslam
author_facet Amod, Aslam
author_sort Amod, Aslam
collection PubMed
description This review describes a presentation at a recent symposium entitled “SUs in the treatment of T2DM: a fresh look and new insights” on Wednesday September 18, 2019 at the 55th Annual Meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain. It examines the current role of sulfonylureas (SUs) in the management of type 2 diabetes mellitus (T2DM) and gives the author’s personal perspective of how this therapeutic class has performed in both local and international guidelines. The place of SUs within current guidelines is highlighted, and a critical appraisal of the reasons for the differences between guidelines given. Finally, comparison of evidence-based guidelines and consensus reports is discussed.
format Online
Article
Text
id pubmed-7261304
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-72613042020-06-11 The Place of Sulfonylureas in Guidelines: Why Are There Differences? Amod, Aslam Diabetes Ther Review This review describes a presentation at a recent symposium entitled “SUs in the treatment of T2DM: a fresh look and new insights” on Wednesday September 18, 2019 at the 55th Annual Meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain. It examines the current role of sulfonylureas (SUs) in the management of type 2 diabetes mellitus (T2DM) and gives the author’s personal perspective of how this therapeutic class has performed in both local and international guidelines. The place of SUs within current guidelines is highlighted, and a critical appraisal of the reasons for the differences between guidelines given. Finally, comparison of evidence-based guidelines and consensus reports is discussed. Springer Healthcare 2020-04-22 2020-06 /pmc/articles/PMC7261304/ /pubmed/32323155 http://dx.doi.org/10.1007/s13300-020-00811-3 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Review
Amod, Aslam
The Place of Sulfonylureas in Guidelines: Why Are There Differences?
title The Place of Sulfonylureas in Guidelines: Why Are There Differences?
title_full The Place of Sulfonylureas in Guidelines: Why Are There Differences?
title_fullStr The Place of Sulfonylureas in Guidelines: Why Are There Differences?
title_full_unstemmed The Place of Sulfonylureas in Guidelines: Why Are There Differences?
title_short The Place of Sulfonylureas in Guidelines: Why Are There Differences?
title_sort place of sulfonylureas in guidelines: why are there differences?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261304/
https://www.ncbi.nlm.nih.gov/pubmed/32323155
http://dx.doi.org/10.1007/s13300-020-00811-3
work_keys_str_mv AT amodaslam theplaceofsulfonylureasinguidelineswhyaretheredifferences
AT amodaslam placeofsulfonylureasinguidelineswhyaretheredifferences

Ejemplares similares